Furthermore, “...Dysregulation of these core pathways and processes through mutation can explain the major features of pancreatic tumorigenesis.” Jones et al. [30] indicate that genetic alterations in the CDKN2A, SMAD4, and TP53 tumor suppressor genes and in the KRAS oncogene have been identified in this lethal cancer. This evidence concerns the gene TP53 and cancer.